Clinical and Translational Radiation Oncology

Papers
(The median citation count of Clinical and Translational Radiation Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation42
Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy26
Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance23
Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer20
In response to Chuong et al.19
Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factors18
Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study17
HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases – A dosimetric comparison study of three radioablative techniques16
Exploring long-term outcomes following CyberKnife robotic radiosurgery for trigeminal neuralgia15
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center13
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan12
In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors12
18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer11
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer10
Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation10
Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins10
The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy10
Impact of reduced margin pelvic radiotherapy on gastrointestinal toxicity and outcome in gynecological cancer9
Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study9
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy9
Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer9
Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis8
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience8
Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer8
The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis8
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity8
Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors8
Treatment of an unresectable cardiac angiosarcoma using paclitaxel and image guided radiotherapy: Case report and literature review7
Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease7
A simple solution to create a custom scalp-sparing helmet to prevent alopecia in patients undergoing total skin electron beam therapy for cutaneous T cell lymphoma7
Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer7
Prospective Pilot study of Quality of Life in patients with severe late-radiation-toxicity treated by Low hyperbaric-oxigen-therapy7
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial7
Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies7
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives7
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter ret7
Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT)7
Incorporating axillary-lateral thoracic vessel juncture dosimetric variables improves model for predicting lymphedema in patients with breast cancer: A validation analysis7
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments7
Radiomics biopsy signature for predicting survival in patients with spinal bone metastases (SBMs)6
A knowledge graph representation of baseline characteristics for the Dutch proton therapy research registry6
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients6
Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy alone6
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy6
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature 6
Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome6
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials6
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control6
Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the diagnosis of recurrent colorectal cancers6
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors6
GI factors, potential to predict prostate motion during radiotherapy; a scoping review6
Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)6
Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience6
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial6
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how6
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy6
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review5
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors5
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of “difficult to treat” non melanoma skin cancer5
Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer5
Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature5
Individual benefit in heart sparing during DIBH-supported left breast radiotherapy5
Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy5
X-rays minibeam radiation therapy at a conventional irradiator: Pilot evaluation in F98-glioma bearing rats and dose calculations in a human phantom5
Postmastectomy radiation therapy in breast cancer patients with micrometastatic disease in sentinel node dissection: A cohort study and meta-analysis5
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer5
Radiotherapy induces an increase in serum antioxidant capacity reflecting tumor response4
Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis4
Ex vivo radiation sensitivity assessment for individual head and neck cancer patients using deep learning-based automated nuclei and DNA damage foci detection4
The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey4
Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC4
Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT4
First treatments for Lattice stereotactic body radiation therapy using magnetic resonance image guided radiation therapy4
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma4
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic4
Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume4
An impact model to understand and improve work-life balance in early-career researchers in radiation oncology4
PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer4
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer4
Stereotactic body radiation therapy to postpone systemic therapy escalation for castration-resistant prostate cancer: A multicenter retrospective analysis4
Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models4
Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases4
Determining the gross tumor volume for hepatocellular carcinoma radiotherapy based on multi-phase contrast-enhanced magnetic resonance imaging4
Application and progress of artificial intelligence in radiation therapy dose prediction4
A time-resolved clonogenic assay for improved cell survival and RBE measurements4
Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial4
Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC4
Redefining postmastectomy radiation contouring in the era of immediate breast reconstruction: An accurate assessment of local recurrence risk4
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies4
Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy4
Letter to the Editor4
Clinical implementation of RTT-only CBCT-guided online adaptive focal radiotherapy for bladder cancer4
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility4
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis4
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging4
Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale 4
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer4
Extramedullary hematopoiesis causing spinal cord compression in polycythemia vera: A case report and literature review4
Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy4
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)4
Dynamic changes in cardiac biomarkers in radiotherapy for oesophageal cancer and their correlations with cardiac radiation dosimetry4
Comment on Hunt et al., “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”4
Radiation response assessment of organoids derived from patients with pancreatic cancer4
C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect4
Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy3
New curative approach using embolization followed by moderate-dose radiotherapy after surgical failure for large right heart metastasis3
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study3
Considerations regarding carotid artery dose in radiotherapy of the cervical spine3
Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function3
Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule3
Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges3
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)3
Do We Have a Winner? Advocating for SBRT in HCC Management3
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study3
ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy3
The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy3
#radonc: Growth of the global radiation oncology Twitter network3
Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy3
10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event3
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial3
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density3
4D-MRI assisted stereotactic body radiation therapy for unresectable colorectal cancer liver metastases3
Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma3
A total inverse planning paradigm: Prospective clinical trial evaluating the performance of a novel MR-based 3D-printed head immobilization device3
Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma3
Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre3
Association between radiotherapy protocol variations and outcome in the CONVERT trial3
Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis3
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial3
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases3
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study3
Rate of pachymeningeal failure following adjuvant WBRT vs SRS in patients with brain metastases3
Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk3
Effects of proton therapy on regional [18F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancer3
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group3
Voluntary versus ABC breath-hold in the context of VMAT for breast and locoregional lymph node radiotherapy including the internal mammary chain2
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy2
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC2
Statistical fundamentals on cancer research for clinicians: Working with your statisticians2
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal 2
Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer – Multi-centre study2
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence2
Realizing the value of complex medical technology: Demonstrating cost-effectiveness is not enough2
Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience2
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)2
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol2
Re-irradiation to the prostate using stereotactic body radiotherapy (SBRT) after initial definitive radiotherapy – A systematic review and meta-analysis of recent trials2
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients2
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study2
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study2
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterizat2
A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT)2
Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma2
The impact of rectal spacers in MR-guided adaptive radiotherapy2
Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients2
Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review2
Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning2
Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis2
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer2
Artificial intelligence to predict outcomes of head and neck radiotherapy2
Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy2
Comment on Hunt et al, “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”2
MR-guided stereotactic radiation therapy for head and neck cancers2
Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors2
Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy – Results from European and Latin American surveys2
Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma2
Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer2
Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma2
Comparing supervised and semi-supervised machine learning approaches in NTCP modeling to predict complications in head and neck cancer patients2
Personalizing dental screening and prevention protocols in dentulous patients with oropharyngeal cancer undergoing radiotherapy: A retrospective cohort study2
Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature2
Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario2
Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy2
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac2
Stereotactic body radiation therapy in patients with centrally located hepatocellular carcinoma: A retrospective, single-arm, multi-center study2
A phase I clinical trial evaluating the application of hydrogel in reducing rectal dose during cervical cancer brachytherapy2
Anatomical and dosimetric variations during volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma after induction therapy: Implications for adaptive radiation the2
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre2
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center cli2
A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer2
Impact of discrimination on training and career of radiation oncologists in France2
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer2
Analysis of the electron-stream effect in patients treated with partial breast irradiation using the 1.5 T MR-linear accelerator2
External validation of Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose (CHyLL) for predicting major adverse cardiac events after lung cancer radi2
Impact of perineural tumor spread in head and neck adenoid cystic carcinoma for carbon-ion radiotherapy2
Erratum regarding missing Declaration of Competing Interest statements in previously published articles2
Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?2
A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma2
Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy based-chemoradiation therapy for newly diagnosed glioblastoma: A multi-institutional study2
Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer2
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study2
A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS2
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma2
Temporary halo fixation and radiotherapy as alternative to long-construct spondylodesis in patients with multiple unstable cervical metastases2
Fractionated stereotactic radiotherapy of brainstem metastases – Clinical outcome and prognostic factors2
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer2
Prognostic implications of HIF-1α expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT)2
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma2
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity2
Associations between patient-reported outcomes and radiation dose in patients treated with radiation therapy for primary brain tumours2
Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain2
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study2
Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience2
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation1
Weekly ultra-hypofractionated radiotherapy in localised prostate cancer1
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures1
High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose calculation1
Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients1
Factors associated with complex oral treatment device usage in patients with head and neck cancer1
Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results1
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma1
Extreme hypofractionated stereotactic radiotherapy for localized prostate Cancer: Efficacy and late urinary toxicity according to transurethral resection of the prostate history1
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis1
Reply to comments on “Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation”1
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience1
Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey1
Men’s perceptions and preferences regarding prostate cancer radiation therapy: A systematic scoping review1
Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy1
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study1
Lattice Radiation Therapy in clinical practice: A systematic review1
Clinical evaluation of a deep learning CBCT auto-segmentation software for prostate adaptive radiation therapy1
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherap1
Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (french society of urological radiation oncologists) recommendations using a national two-round modified Delphi surve1
Management of glioblastoma in elderly patients: A review of the literature1
Influence of eye movement on lens dose and optic nerve target coverage during craniospinal irradiation1
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer1
Institutional experience of using active breathing control for paediatric and teenage patients receiving thoraco-abdominal radiotherapy1
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer1
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach1
Benchmarking machine learning approaches to predict radiation-induced toxicities in lung cancer patients1
Intrafractional motion detection for spine SBRT via X-ray imaging using ExacTrac Dynamic1
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia1
Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis1
The role of image-guided radiotherapy in prostate cancer: A systematic review and meta-analysis1
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients1
GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer1
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer1
Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework1
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey1
Quantifying radiation-induced breast fibrosis by shear-wave elastography in patients with breast cancer: A 12-months-follow-up data of a prospective study1
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study1
Methodological guide for assessing the carbon footprint of external beam radiotherapy: A single-center study with quantified mitigation strategies1
Reduction of intrafraction pancreas motion using an abdominal corset compatible with proton therapy and MRI1
Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) – A phase I trial1
Stereotactic lung reirradiation for local relapse: A case series1
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institutio1
In regard to Kim et al1
MRI-guided adaptive radiotherapy for prostate cancer: When do we need to account for intra-fraction motion?1
Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study1
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplana1
0.052288055419922